These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3842105)

  • 21. [Accumulation of aluminum in the dialyzed patient: incidence, causes and possibilities of prevention].
    Sulková S; Laurincová Z; Lapcík O; Dlhopolcek P; Stodolová E; Komonová D
    Cas Lek Cesk; 1989 Jan; 128(1):16-9. PubMed ID: 2713883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients.
    Suzuki M; Hirasawa Y; Tanizawa T
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S51-5. PubMed ID: 8608664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of an intra-laboratory reference material--determination of the aluminum content of a pooled 5% albumin (human) solution by ETAAS, MFS and ICP-AES.
    Progar JJ; May JC; Rains TC; Watters RL; Yu L
    Biologicals; 1996 Jun; 24(2):87-93. PubMed ID: 8889054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
    Hudnell HK
    Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological monitoring of aluminium in renal patients.
    de Wolff FA; van der Voet GB
    Clin Chim Acta; 1986 Oct; 160(2):183-8. PubMed ID: 3780008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair. Reference values.
    Goullé JP; Mahieu L; Castermant J; Neveu N; Bonneau L; Lainé G; Bouige D; Lacroix C
    Forensic Sci Int; 2005 Oct; 153(1):39-44. PubMed ID: 15979835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy.
    Reusche E; Koch V; Friedrich HJ; Nünninghoff D; Stein P; Rob PM
    Clin Neuropathol; 1996; 15(6):342-7. PubMed ID: 8937781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rubidium deficiency in dialysis patients.
    Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Pietra R; Fortaner S; Jacono F; Angelini G; Gallieni M; Fop F; Sabbioni E
    J Nephrol; 2001; 14(3):169-75. PubMed ID: 11439740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
    Ther Apher Dial; 2003 Feb; 7(1):3-35. PubMed ID: 12921111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subacute fatal aluminum poisoning in dialyzed patients: post-mortem toxicological findings.
    de Wolff FA; Berend K; van der Voet GB
    Forensic Sci Int; 2002 Aug; 128(1-2):41-3. PubMed ID: 12208020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
    Sprague SM; Corwin HL; Tanner CM; Wilson RS; Green BJ; Goetz CG
    Arch Intern Med; 1988 Oct; 148(10):2169-72. PubMed ID: 3178374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of the plasma aluminum concentration of hemodialysis patients].
    Kuleva V; Petrov I; Antonov S; Kiriakov Z
    Vutr Boles; 1984; 23(2):51-5. PubMed ID: 6741112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
    Günther K; Winnefeld K; Stein G; Sperschneider H; Schröter H; Fünfstück R
    Z Urol Nephrol; 1986 Oct; 79(10):569-76. PubMed ID: 3811645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dialysis encephalopathy and aluminum poisoning? Correlated clinical, pathologic-anatomic and spectrometric findings].
    Weiller C; Spiegel P; Van de Vijver F
    Nervenarzt; 1986 Aug; 57(8):461-4. PubMed ID: 3092120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical aspects of quantification of aluminum.
    Chan S; Gerson B
    Clin Lab Med; 1990 Jun; 10(2):423-33. PubMed ID: 2197056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of aluminum in whole blood, plasma, serum, and water by a single procedure using flameless atomic absorption spectrophotometry.
    van der Voet GB; de Haas EJ; de Wolff FA
    J Anal Toxicol; 1985; 9(3):97-100. PubMed ID: 4010240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.